Paras Health Panchkula saves life of 81-year-old cancer survivor with rare Micra VR2 pacemaker implant
The cancer survivor, unfit for a conventional pacemaker, underwent the scarless Micra VR2 implant through the thigh and was discharged safely within 24 hours.
Panchkula, September 20, 2025: Paras Health Panchkula has successfully implanted the world’s smallest and latest generation pacemaker, Micra VR2, in an 81-year-old male cancer survivor with multiple health complications. The rare, high-risk procedure was performed on September 4, 2025, and the patient was safely discharged within 24 hours, marking a major milestone in advanced cardiac care in the region.
The patient, Mr. C. Singh[TW1] , had a complex medical history. A survivor of neck cancer with multiple radiation therapies, he had extensive chest scarring, vocal cord paralysis, and depended on a feeding tube for nutrition. His frail condition was further complicated by repeated infections and frequent episodes of unconsciousness. Investigations revealed complete heart block, a life-threatening condition requiring urgent intervention.
However, due to his age, frailty, and scarred chest, a conventional pacemaker was not an option. Explaining the decision, the treating cardiologist Dr. Naveen Aggarwal, Director, Cardiology – Interventional said, “This was a highly challenging case. Given the patient’s history, a traditional pacemaker carried significant risks. The Micra VR2 provided a safe and effective alternative. It leaves no scar, avoids infection-prone chest pockets, and ensures faster recovery. The patient has not experienced any further episodes of unconsciousness since the implant.”
Highlighting the achievement, Dr. Pankaj Mittal, Facility Director at Paras Health Panchkula, said, “This successful case demonstrates our ability to manage some of the most complex and high-risk patients. With innovations like Micra VR2, we are setting new benchmarks in cardiac care.”
The Micra VR2 pacemaker represents the next generation of leadless cardiac pacing technology. Unlike conventional systems, it eliminates the need for leads and chest incisions, reducing infection risks and improving patient comfort. Its updated delivery system offers up to a 66% reduction in catheter tip pressure and a 28.5% lower predicted risk of perforation, while preserving the simplicity of the implant procedure.
Since the implantation, Mr. Singh has regained stability and is living without recurrence of fainting episodes. The case reinforces Paras Health Panchkula’s position as a leading centre for advanced cardiac interventions in North India, combining cutting-edge technology with patient-first care.
